Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 3
2002 1
2003 5
2004 2
2005 1
2006 2
2007 1
2009 2
2010 2
2011 2
2012 4
2013 2
2014 3
2015 1
2016 5
2017 5
2018 3
2019 1
2020 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Safety differentiation: emerging competitive edge in drug development.
Uteng M, Urban L, Brees D, Muller PY, Kullak-Ublick GA, Bouchard P, Tougas G, Chibout SD. Uteng M, et al. Among authors: chibout sd. Drug Discov Today. 2019 Jan;24(1):285-292. doi: 10.1016/j.drudis.2018.09.009. Epub 2018 Sep 19. Drug Discov Today. 2019. PMID: 30244081 Free article. Review.
Toxicogenomics in drug development.
Guerreiro N, Staedtler F, Grenet O, Kehren J, Chibout SD. Guerreiro N, et al. Among authors: chibout sd. Toxicol Pathol. 2003 Sep-Oct;31(5):471-9. doi: 10.1080/01926230390224656. Toxicol Pathol. 2003. PMID: 14692614 Review.
Bile acids in drug induced liver injury: Key players and surrogate markers.
Schadt HS, Wolf A, Pognan F, Chibout SD, Merz M, Kullak-Ublick GA. Schadt HS, et al. Among authors: chibout sd. Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):257-266. doi: 10.1016/j.clinre.2015.12.017. Epub 2016 Feb 10. Clin Res Hepatol Gastroenterol. 2016. PMID: 26874804 Free article. Review.
Investigative safety science as a competitive advantage for Pharma.
Moggs J, Moulin P, Pognan F, Brees D, Leonard M, Busch S, Cordier A, Heard DJ, Kammüller M, Merz M, Bouchard P, Chibout SD. Moggs J, et al. Among authors: chibout sd. Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1071-82. doi: 10.1517/17425255.2012.693914. Epub 2012 Jul 7. Expert Opin Drug Metab Toxicol. 2012. PMID: 22769724 Review.
Unaltered hepatic wound healing response in male rats with ancestral liver injury.
Beil J, Perner J, Pfaller L, Gérard MA, Piaia A, Doelemeyer A, Wasserkrug Naor A, Martin L, Piequet A, Dubost V, Chibout SD, Moggs J, Terranova R. Beil J, et al. Among authors: chibout sd. Nat Commun. 2023 Oct 10;14(1):6353. doi: 10.1038/s41467-023-41998-w. Nat Commun. 2023. PMID: 37816736 Free PMC article.
Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
Schadt HS, Wolf A, Mahl JA, Wuersch K, Couttet P, Schwald M, Fischer A, Lienard M, Emotte C, Teng CH, Skuba E, Richardson TA, Manenti L, Weiss A, Graus Porta D, Fairhurst RA, Kullak-Ublick GA, Chibout SD, Pognan F, Kluwe W, Kinyamu-Akunda J. Schadt HS, et al. Among authors: chibout sd. Toxicol Sci. 2018 May 1;163(1):265-278. doi: 10.1093/toxsci/kfy031. Toxicol Sci. 2018. PMID: 29432567 Free article.
Mapping the epigenome--impact for toxicology.
Marlowe J, Teo SS, Chibout SD, Pognan F, Moggs J. Marlowe J, et al. Among authors: chibout sd. EXS. 2009;99:259-88. doi: 10.1007/978-3-7643-8336-7_10. EXS. 2009. PMID: 19157065 Review.
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective.
Heikkinen I, Eskola S, Acha V, Morrison A, Walker C, Weil C, Bril A, Wegner M, Metcalfe T, Chibout SD, Chlebus M. Heikkinen I, et al. Among authors: chibout sd. Drug Discov Today. 2023 May;28(5):103526. doi: 10.1016/j.drudis.2023.103526. Epub 2023 Feb 14. Drug Discov Today. 2023. PMID: 36792005 Free article.
45 results